Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 5 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis.
Br J Pharmacol. 2021 Mar;178(6):1373-1387. doi: 10.1111/bph.15386. Epub 2021 Feb 20.
Br J Pharmacol. 2021.
PMID: 33486755
Free article.
Review.
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.
Nozal V, Martínez-González L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, Pérez-Cuevas E, Knapp S, Lietha D, Ramírez D, Petralla S, Monti B, Gil C, Martín-Requero A, Palomo V, de Lago E, Martinez A.
Nozal V, et al. Among authors: gomez almeria m.
J Med Chem. 2022 Jan 27;65(2):1585-1607. doi: 10.1021/acs.jmedchem.1c01942. Epub 2022 Jan 3.
J Med Chem. 2022.
PMID: 34978799
Item in Clipboard
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis.
Gómez-Almería M, Burgaz S, Costas-Insua C, Rodríguez-Cueto C, Santos-García I, Rodríguez-Crespo I, García C, Guzmán M, de Lago E, Fernández-Ruiz J.
Gómez-Almería M, et al.
Int J Mol Sci. 2021 Nov 20;22(22):12533. doi: 10.3390/ijms222212533.
Int J Mol Sci. 2021.
PMID: 34830414
Free PMC article.
Item in Clipboard
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis.
Rodríguez-Cueto C, Gómez-Almería M, García Toscano L, Romero J, Hillard CJ, de Lago E, Fernández-Ruiz J.
Rodríguez-Cueto C, et al. Among authors: gomez almeria m.
Brain Pathol. 2021 Nov;31(6):e12972. doi: 10.1111/bpa.12972. Epub 2021 May 13.
Brain Pathol. 2021.
PMID: 33983653
Free PMC article.
Item in Clipboard
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.
Martínez-González L, Gonzalo-Consuegra C, Gómez-Almería M, Porras G, de Lago E, Martín-Requero Á, Martínez A.
Martínez-González L, et al. Among authors: gomez almeria m.
Int J Mol Sci. 2021 Aug 20;22(16):8975. doi: 10.3390/ijms22168975.
Int J Mol Sci. 2021.
PMID: 34445680
Free PMC article.
Item in Clipboard
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Burgaz S, García C, Gonzalo-Consuegra C, Gómez-Almería M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N, Rodríguez-Cueto C, de Lago E, Muñoz E, Fernández-Ruiz J.
Burgaz S, et al. Among authors: gomez almeria m.
Molecules. 2021 Dec 16;26(24):7643. doi: 10.3390/molecules26247643.
Molecules. 2021.
PMID: 34946726
Free PMC article.
Item in Clipboard
Cite
Cite